Listen to The Lancet Neurology
Medical
The Lancet Neurology is a monthly journal, renowned for the publication of high-quality peer-reviewed research, reviews, and analysis from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue, with occasional interviews with an author of a key article.
Location:
United States
Description:
The Lancet Neurology is a monthly journal, renowned for the publication of high-quality peer-reviewed research, reviews, and analysis from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue, with occasional interviews with an author of a key article.
Language:
English
Episodes
Next-generation sequencing and clinical neurology
4/12/2019
Brent Fogel talks to The Lancet Neurology about his work on large-scale genomic analysis.
Duration:00:07:46
Role of astroglia in Alzheimer's disease
3/14/2019
Amaia Arranz and Bart De Strooper discuss their Review on the role of astroglia in Alzheimer's disease.
Duration:00:15:04
Sleep disturbance and dementia risk
2/12/2019
Michael Irwin (University of California, Los Angeles, USA) discusses a Review concerning potential links of sleep disturbance and possible increased risk of Alzheimer's disease dementia.
Duration:00:11:11
Frailty and Alzheimer's
1/22/2019
Lindsay Wallace and Kenneth Rockwood join The Lancet Neurology to talk about their work on the association between frailty and the onset of Alzheimer's disease.
Duration:00:12:31
Stroke–heart syndrome
11/22/2018
In the latest podcast from The Lancet Neurology, Jan Scheitz discusses the development of stroke–heart syndrome.
Duration:00:10:39
Thrombectomy for ischaemic stroke
11/21/2018
Bruce Campbell joins The Lancet Neurology to discuss his systematic review of the HERMES collaboration.
Duration:00:08:49
Epileptic seizures
10/16/2018
Mark Cook and Phillippa Karoly join The Lancet Neurology to discuss their retrospective study of cyclical patterns in epileptic seizures.
Duration:00:11:41
Cerebral white matter demyelination in multiple sclerosis
9/18/2018
Bruce Trapp and Daniel Ontaneda discuss their retrospective study investigating cortical neuronal loss and cerebral white-matter demyelination in mulitple sclerosis.
Duration:00:15:30
Autoimmune encephalitis after herpes simplex encephalitis
7/24/2018
Josep Dalmau joins The Lancet Neurology to discuss recognition and outcomes of autoimmune encephalitis after herpes simplex encephalitis.
Duration:00:10:29
Network imaging biomarkers
6/16/2018
David Eidelberg and Katharina Schindelbeck join The Lancet Neurology to explain their new review of the applications of network imaging biomarkers in Parkinson's disease.
Duration:00:20:21
Progressive multifocal leukoencephalopathy
5/4/2018
Eugene Major and David Clifford join The Lancet Neurology to discuss their review of pathogenesis and treatments for progressive multifocal leukoencephalopathy.
Duration:00:19:45
Antiepileptic drugs and risk of congenital malformation
4/30/2018
Torbjörn Tomson discusses the issue of antiepileptic drugs during pregnancy and the risk of major congenital malformations.
Duration:00:07:57
Seizure detection and reporting in epilepsy: The Lancet Neurology: February 13, 2018
2/14/2018
Christian Elger discusses the diagnostic challenges in epilepsy with the detection and reporting of seizures.
Duration:00:06:03
MS McDonald criteria revisions: The Lancet Neurology: February 2018
1/19/2018
Jeffrey Cohen joins us to talk about the process of updating and revising the McDonald criteria for diagnosis of MS.
Duration:00:09:01
GWAS on dementia with Lewy bodies: The Lancet Neurology: January, 2018
12/16/2017
Jose Bras discusses his study of the genetic architecture of dementia with Lewy bodies.
Duration:00:06:18
Traumatic Brain Injury: The Lancet Neurology: November 7, 2017
11/7/2017
Andrew Maas and David Menon, lead authors, discuss The Lancet Neurology Commission on traumatic brain injury and outline the worldwide burden.
Duration:00:37:40
TDP-43 and Alzheimer's disease: The Lancet Neurology: November 2017
10/11/2017
Keith Josephs talks about considering TDP-43 as a potential factor related to increased rates of hippocampal atrophy in patients with Alzheimer's disease.
Duration:00:09:09
Biomarkers in stroke recovery: The Lancet Neurology: October 2017
9/13/2017
Cathy Stinear discusses her review of biomarkers that might predict motor recovery after stroke.
Duration:00:07:00
Genetic variants and Huntington's: The Lancet Neurology: September 2017
8/9/2017
Lesley Jones and Sarah Tabrizi talk about their work on the identification of genetic markers associated with the progression of Huntington's disease.
Duration:00:18:40
Simvastatin and MS: The Lancet Neurology: August 2017
7/12/2017
Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.
Duration:00:04:50